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EFFECT OF MAST CELL PRODUCTS ON 
CAPILLARY PERM EABILITY
E dward D r a n e  C r a b b
The physiological implications of changes in capillary permeability are pro­
foundly significant under normal conditions as well as in "disease states" (640) 
or in certain well-defined pathological conditions. Proper capillary function is so 
very important that Szent-Gyorgyi (568) looks upon it "as a mechanism which, 
in its precision, greatly surpasses the finest Swiss watch", and he regards capillary 
fragility as an indication "that this mechanism is out of order". The term capil­
lary fragility" as used by many writers includes all stages of "increased capillary 
permeability", but the term "increased capillary fragility" should be limited to 
"chemical lesions in the capillary wall, specifically in intercellular substance" 
(545), or to other drastic conditions, including rupture of the collecting venule of 
the capillary bed (339). This idea is recapitulated in the statement that an intact 
capillary system indicates a solvent body (66).
The work of Kramer and Kramer, 1953, indicates that multiple factors are 
involved in maintaining an intact capillary system (66) for they have shown that 
hormones of the pituitary-adrenal system play a significant part in the control of 
capillary resistance (623). Other investigators show that fasting profoundly in­
creases capillary resistance and that realimentation with an isocaloric protein diet 
rapidly causes the capillaries to return to the state of normal permeability (623). 
Disturbance in the ionic balance (339), in enzymic activity (18, 20, 21, 148) and, 
in short, the activity of almost any disturbing agent results in change in capillary 
permeability.
Altering the calcium-potassium ratios, increasing the amount of potassium, or 
reducing the amount, or omitting, calcium in perfusion experiments caused swelling 
of the intercellular cement substance and a great increase in permeability of the 
capillaries in the living mammal; while substituting magnesium for calcium ions 
also caused the extracellular cement to transform into a jelly-like, eythrocyte- 
permeable material, and excessive amounts of calcium hardened the cement and 
decreased its permeability (649).
Ascorbic acid-deficiency is conducive to capillary fragility in proportion to the 
severity of the deficiency. The capillary bed in vitamin C -deficient guinea pigs 
responded to experimental trauma by formation of petechiae much more readily 
than in guinea pigs receiving normal amounts of ascorbic acid (339).
Zweifach (647, 648) found that merely stroking the overlying peritoneum with 
a microdissecting needle caused increased capillary dilation and permeability in
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the exteriorized mesentery of the mouse, and it has been found that similar effects 
are produced by lightly applying a camels' hair brush (84).
The relations of mast cell products to changes in the permeability of capillaries 
apparently involve substances and their effects which are not fully understood. 
A substance, indistinguishable from 5-hydroxytryptamine by its chemical and 
biological properties, has been obtained from peritoneal mast cells of the rat 
(43, 493) and later shown to be formed by mast cells from 5-hydroxytryptophan 
(334). This substance, 5-hydroxytryptamine or serotonin, was found to be present 
in the skin and subcutaneous connective tissue of rats in amounts proportional 
to the mast cell population of these tissues (493).
Since it has been generally conceded that 5-hydroxytryptamine (serotonin, 
5-hydroxy-3-(B-aminoethyl)indole) is a "vasoconstrictor found in sera of mam­
mals" (389) it is difficult to envisage this hormone as being a substance which 
strongly increases capillary permeability. Nevertheless, results of the work of 
Benditt and his colleagues (43, 334, 493) certainly indicate that this is the case. 
Rowley and Benditt (493) state that the combined evidence obtained "makes it 
very likely that the edema-producing agent released by mast cell-damaging 
substances is 5-hydroxytryptamine". It thus appears from the work of Rowley 
and Benditt (493) that the effects of serotonin on peripheral, especially dermal, 
capillary permeability are similar to, perhaps even identical with, those com­
monly attributed to histamine.
If one disregards for the moment its synthesizing and storing functions, the 
part played by the mast cell in initiating and sustaining hyperemia and increased 
capillary permeability, by releasing histamine, heparin, probably serotonin, and 
other substance, is the mast cell's most significant contribution to the physiologic 
and metabolic processes. The work of several investigators (402, 475) strongly 
indicates that mast cells are a very important, if not by far the most important, 
source of histamine released in the skin. Other investigators have shown that 
there is a direct correlation between the number of mast cells and the amount of 
histamine in the skin (382, 402, 473, 474, 617). In one laboratory it was shown 
that the skin from the hands and feet of untreated rats contained 61.0 f x g / g  of 
histamine, but in rats pretreated with compound 48/80, which is nearly specific 
for mast cells, skin from the feet contained only 8.6 ug / g ;  skin from the dorsum 
of the normal rats contained 27.9 ug /g  and in those pretreated with compound 
48/80 the dorsal skin contained only 5.4 ug/g. Skin from both regions was rich 
in mast cells, but that from the back contained only about 75 per cent as many 
mast cells as that from the hands and feet (402). However, there are reasons for 
believing that mast cells also increase capillary permeability by secreting a sub­
stance which has a solvent effect on the intercellular cement material of the 
endothelium and on the adsorbed protein film covering the endothelial surface
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(380). If this point can be established and the conclusions of Lewis, 1927, that 
markedly increased capillary permeability is dependent upon certain chemico- 
physical changes in the capillary wall (402) are valid, the significance of mast 
cells in normal and greatly increased capillary permeability will be very much 
enhanced.
Mast cells also function in the formation of hyaluronic acid in pericapillary 
connective tissue ground substance (19, 21, 22, 23, 93, 384, 565). Hyaluronic acid 
actively opposes the spread of fluid in the tissues (18, 21, 148, 550, 648) unless 
it is altered by some substance, such as pituitary gonadotropic hormones, possibly 
estrogens (550) or hyaluronidase (18, 20, 148, 479). Since it is indicated that 
hyaluronidase is produced in the connective tissue in anaphylaxis (551) there is 
good reason to suspect that this enzyme is also produced whenever an excess of 
histamine is released. Duran-Reynal's, 1947, suggestion that hyaluronidase regu­
lates capillary permeability (13) apparently supports this view. He also points 
out that in addition to hyaluronidase other chemical regulators, such as hypophys­
eal gonadotropic hormones and possibly estrogen, play a significant part in 
increasing the permeability of ground substance (550). It has also been shown by 
various investigators that several of the bioflavonoids, including hesperidin methyl 
chalone, possess effective antihyaluronidase activity and that ascorbic acid po­
tentiates bioflavonoid activity (479). Demonstration that oral administration of 
hesperidin methyl chalone reduces the spreading reaction of intracutaneously 
injected hyaluronidase (479) strongly indicates the significance of hyaluronic 
acid in preventing increased capillary permeability.
The dilated capillaries and edema produced by topical applications of weak 
solutions of histamine to the base of human finger nails (47) indicated that hyaluro­
nidase, or some other spreading substance, altered the nature of the connective 
tissue ground substance, presumably by changing some of the hyaluronic acid 
from a gel-like to a sol-like state (148). Indeed, because of the resistance to connec­
tive tissue permeability afforded by normal hyaluronic acid, the formation of a 
significant edema would, at least as a rule, presuppose degradation of the hyalu­
ronic acid in the connective tissue ground substance.
There is good reason to believe that all cells contain at least a physiological 
trace of histamine, and it has been shown that appreciable quantities of histamine 
can readily be released from certain of these cells (60, 108, 155, 186, 238, 336, 
503, 619). However, the mast cell appears to be the only cell which contains a 
maximum amount of stored histamine and at the same time is cytologically and 
cytochemically adapted to the requirements for general investigation of the 
relations of the release of endogenous histamine to increased capillary permeability, 
as the works of several investigators indicate (402, 473, 474, 617).
McGovern (380) suggests that mast cells also secrete a "spreading substance"
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which, by altering "the consistency of the endothelial cement lines" and endothe­
lial surface film, is to a great extent responsible for regulating capillary permea­
bility. He apparently believes that "histamine, heparin and the spreading sub­
stance are components of one secretion of mast cells and that in vivo, they do 
not exist individually" in the rat. It is generally conceded that histamine and 
heparin are stored in mast cells in an inactive, loosely bound form (382, 474), 
but McGovern's (380) suggestion that a spreading substance, histamine and 
heparin are all three components of "one secretion of mast cells" is apparently a 
new approach. The presence of 5-hydroxytryptamine, serotonin, a vasopressor 
substance, in mast cells (43, 334) presents a new angle in determining the func­
tions of the mast cell, for this substance does not seem to harmonize with the 
effects of histamine, heparin, McGovern's "spreading substance" and acid muco­
polysaccharides. Nevertheless, it is held that the presence of 5-hydroxytryptamine 
with heparin and histamine emphasizes the significance of mast cells "as partici­
pants in the reaction to injury" (43).
The view of Manwaring and his colleagues, 1923, that all anaphylactic reactions 
are actually secondary to "increased specific capillary permeability", which is the 
fundamental physiological change evoked in protein sensitization, apparently 
is becoming widely accepted (37). This tenet is supported by the work of Rapaport, 
1941, and others who found that among allergic children having this type of 
capillary fragility, about half of them improved following administration of the 
biofiavone, vitamin P, or vitamin K  (597).
Several investigators hold that the abundance of mast cells in a structure is 
dependent on the amount of connective tissue present (392). I wish to add to this 
statement our observations showing that there is also a vascular requirement, 
for mast cells do not become numerous in the fat of the so-called hibernating 
gland in the hamster until hyperemia has appeared, and then the increase in 
mast cells occurs in the region of the fat body where conversion of white to brown 
fat has set in. Also, it is well established that mast cells have a marked tendency 
to align themselves along, or to "cuff" or "skirt" (Heller's Mastzellenhetten) 
arterioles and capillaries (392, 453, 621).
V asom otion
The amount of blood supplied to a structure is normally governed by controlling 
the diameter of the blood vessels supplying that structure —  that is, by vasodila­
tion and vasoconstriction. The significant point of vasomotion is that it is generally 
conceded to be the most important primary method by which capillary permea­
bility changes are effected.
It is held that certain agents may effect increased capillary permeability with­
out altering the diameter of the capillaries. These agents usually, by indirect
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action, alter the physical and/or chemical nature of the endothelium, perivascular 
sheath and/or connective tissue ground substance. However, it appears to be 
paradoxical to consider the possibility of causing an appreciable alteration in any 
or all three of these components of the blood tissue barrier without producing 
changes in the diameter of the involved capillary. Some of the agents or factors 
usually considered in this category are pH and tonicity changes in the extra 
cellular fluids. Thus, it is pointed out, that in experimental work loss in capillary 
fluid may be caused by hypertonic solutions of albumin, glucose, sodium chloride 
or sucrose shrinking and separating the endothelial cells with consequent capillary 
leakage (649). Excessive amounts of sodium fed to hamsters were responsible for 
capillary changes which were indicated by "numerous petechiae in the capillary 
bed of the cheek pouch" (339).
The ground substance may be altered by thyroid hormone (20) which may 
alter its salt-water relations and the relations of hyaluronate compounds and 
connective tissue fibers (20, 649), and other agents. X  irradiation (649), and ab­
sence or insufficiency of ascorbic acid (479, 649), hesperidin (369, 479) or other 
bioflavonoids affect the ground substance and induce increased capillary permea­
bility, or actual fragility, and edema (339, 369, 479, 649). Oral administration of 
hesperidin methyl chalcone has been shown to diminish the spreading reaction 
of hyaluronidase when injected into guinea pigs (479).
T erm in a l  V ascu lar  Structu re
The term vasomotion as used in this work is limited to that part of the terminal 
vascular structure, or "capillary bed" (647), having muscular sheets, bands, or 
fibers in the walls (59, 647). The true capillaries, the walls of which are free of 
muscle fibers (647), are capable of reacting only passively to vasomotion, which 
may cause variations from the normal tone to various degrees of dilation or 
constriction of the arteriolar trunk. Consequently, the volume of blood which 
may flow through the capillaries (except, possibly those possessing Rouget cells 
(329)) under conditions of normal blood pressure is controlled by the diameter 
of the arteriolar trunk. Thus, it appears that local volume changes in true capil­
laries are chiefly the direct result of increased volume, probably with no signifi­
cant local change in pressure, of blood in the arterial trunk of terminal vascular 
structures.
The difficulty of identifying the nature of the blood vessel is often complicated 
by the conditions of the experiment and by physiological or pathological states. 
Also, the rather loose way in which investigators sometimes designate capillaries 
in describing results obtained often causes the reader to wonder whether the 
involved blood vessel is a true capillary or some other part of the terminal vascular 
structure. In this review we have followed, as far as is practical, Zweifach's (647)
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work on in vivo dissection, function and terminology of the terminal vascular 
structures. Most of Zweifach's (647) work was done on blood vessels in the mes­
entery of the mouse. Nevertheless, his structural and functional concepts appear 
to be in agreement with the generally accepted pharmacological actions of sub­
stances producing known effects on peripheral capillaries, such as histamine and 
epinephrine (377, 547).
The terminology and sequence of structures here employed follow: The terminal 
vascular structures comprise the arteriole, precapillary, "arteriolovenular (a-v) 
bridge" (capillary bridge or "permanently open capillary") (647), true capillaries, 
prevenule and venule. The true capillaries arise from the arterioles, precapillaries, 
and a-v bridges (647), and their origins are commonly provided with a muscular 
or endothelial valve-like structure which is opened by dilation of the arteriolar 
trunk. True capillaries may empty into the venous part of the a-v bridge, pre­
venule and/or venule; usually are collapsed during vasoconstriction, or some may 
be collapsed and others contain static blood during the basal level of flow (329) 
but are distended with blood during dilation of the arteriolar trunk of the terminal 
vascular structure (647).
E ffec t s  of A rterio la r  C hanges
Systemic or extensive vasodilation decreased the pressure and rate of flow of 
the contained blood, but at the same time it may greatly increase the permeability 
of the walls of the precapillaries, a-v bridges and, especially, of the true capillaries, 
and thus permit abnormal amounts of plasma, inorganic ions, inordinate amounts 
of protein, corpuscles, and other circulating substances to pass out of the blood 
stream into the tissues (87, 619). This increase in capillary permeability is ex­
tremely important in normal growth, wound healing and maintenance, as well as 
pathological, processes. In pathological conditions these changes may present 
serious problems, for, under the influence of histamine, protein leakage may reach 
5 to 6 times the normal rate of the affected capillaries (238).
Since mast cells are rich in stored histamine (402), it is significant that there is 
a growing tendency for investigators of changes in capillary permeability to attach 
increasing importance to the release of mast cell-histamine as a provocative factor 
in increasing vasodilation and thus increasing permeability of capillaries, especially 
when confined to a delimited area or region.
The consideration of vasomotion for the purpose of this review is limited chiefly 
to the production and control of "active hyperemia" (90), with special emphasis 
on "capillary hyperemia" (90). Local capillary hyperemia results chiefly from the 
action of an agent causing relaxation of the muscle fibers in the wall of the arterio­
lar trunk of the terminal vascular structures, particularly in the arteriolar and 
precapillary regions and, probably, in the a-v bridges. This is held to result in
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increased dilation and a corresponding volume of blood in the arteriolar trunk 
which causes consecutive dilation as the increasing blood volume is forced through 
the relaxed a-v bridge and the previously inactive, or even collapsed, true capil­
laries.
V ario usly  E ffec t ed  V asomotion
Vasomotion, as delimited in this review, may be produced by any one of a variety 
of agents which commonly operate by either stimulating or inhibiting the lamina 
muscularis of the larger blood vessels and/or the terminal vascular structures, 
the muscular bands in the wall of a-v bridges or the muscle fibers which form the 
valves at the origin of the true capillaries. It thus appears that active vasomotion 
is dependent upon the contraction of muscle tissue in the blood vessels to produce 
vasoconstriction and upon relaxation of this muscle tissue to permit vasodilation. 
There is evidence to support the idea that the vasomotor state of the arterial 
trunk of the terminal vascular structure not only controls the state of the true 
capillaries but also markedly influences the tone of the aorta and great arteries, 
including the coronary arteries, and the per minute output of ventricular blood 
(59). Since the true capillaries of mammals are devoid of muscle tissue (647) 
they are incapable of active constriction, but their endothelial walls are capable 
of exerting an appreciable degree of elasticity apparently independently of peri­
cytes or periepithelial cells. Ponder (449) supports this idea by stating that most 
observers do not credit endothelial cells with contractility but attribute all active 
contractility to the " a-v capillaries and metarterioles" which are effective because 
of the smooth muscle in the walls. Thus, there is normally a fairly definite correla­
tion between the diameter, volume of blood flow, and degree of permeability of 
the wall of the true capillaries and a-v bridges and, possibly, also involving the 
precapillaries and arterioles to a certain extent.
It has been estimated that in resting skeletal muscles about 90 per cent of the 
capillaries may be empty and collapsed or in stasis and the remaining 10 per cent 
constricted and virtually inactive, while the blood supply to the resting tissue is 
maintained by a certain alternation of these conditions in the capillaries, and 
that during physical activity blood courses through many of the previously col­
lapsed capillaries (329).
Rouget cells, or pericytes, when present may have a function in constricting 
capillaries (329), but presence of these cells on mammalian capillaries has not been 
established (30, 240, 647). It should also be mentioned that the power of active 
contractility has been ascribed to endothelium in vitro by Levi, 1923, and in vivo 
by the Clarks and others, while some investigators stoutly maintain the inability 
of endothelium per se to contract (13, 449). Nagel, 1934, found that capillary 
endothelium offered little or no resistance to microdissection needles, and the
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little resistance present was due to the connective tissue; therefore, the endothelial 
cells were very readily deformed by any appreciable force. Consequently, endothe­
lial resistance to any force exerted against it is practically negligible, the connective 
tissue 'periepithelium' being chiefly responsible for any resistance to capillary 
distension (84). However, some investigators hold that the flow of blood through 
the capillaries can be reduced, or even stopped, by the endothelial cells becoming 
swollen and distending into the lumen of the capillary (84). We have observed very 
large cuboidal endothelial cells in certain inflamed human tissues, but not in 
any kind of normal tissue. It follows then, that, under normal conditions at least, 
the true capillaries in themselves are essentially inactive and respond primarily 
to the volume and pressure of blood in the muscular part of the terminal vascular 
structure which comprises the a-v bridge, precapillary arteriole, and arteriole.
There is, however, the probability that ionic changes and/or other factors, 
including Starling's, 1896, principle that increased venous pressure increases 
capillary transudation (160,263), may affect capillary permeability independently 
of the muscular part of the terminal vascular structure. Although stimulation of the 
splanchnic nerve was followed by an increase in volume of an intestinal loop 
while it was enclosed in a plethysmograph, whether the resulting hyperemia was 
actually caused by stimulation of the vasodilator nerve or merely by relaxation 
of the intestinal muscle is debatable, for it has been shown that any change in 
intestinal tone is followed by a change in blood flow (599). Uvnas (599) supports 
this latter tenet by pointing out that low concentrations of acetylcholine increase 
intestinal blood flow, while concentrations, sufficiently high to cause contraction 
of the muscle tissue, also reduce intestinal blood flow. Unfortunately, the fact 
that the intestinal mesentery is richly supplied with mast cells, which store 
histamine, or that the least injury or even disturbance causes release of histamine 
apparently was not considered. The manipulation of the intestinal loop incident 
to enclosing it in the plethysmograph would be expected to release a sufficient 
amount of histamine to account for the increased blood flow.
Recent experiments in which the fragility of the capillary bed in the cheek pouch 
was increased by feeding hamsters excessive amounts of sodium, adding 30 per 
cent of fat, and withholding choline or ascorbic acid from the diet of rats or guinea 
pigs and mechanically or electrically stimulating exposed mesenteric vessels showed 
that leakage was due to defective venules and thus demonstrated that the site of 
the escaped blood during increased capillary fragility was the collecting venule 
of the capillary bed (339).
Although it is impractical to rule out neuromuscular relations, the contradictory 
effects obtained with magnesium indicate capillary permeability changes. Defi­
ciency of dietary magnesium caused vasodilation (331), while excess of admin­
istered magnesium depressed the blood vascular and respiratory systems in rats 
(160).
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McCollum and co-workers (331) found that addition of only 1.8 parts per million 
of magnesium to an otherwise adequate diet prevented occurrence of the magne­
sium deficiency syndrome in rats.
The suggestion has been made that some of the various agents which are 
commonly credited with causing vasomotion act indirectly by causing release of 
histamine. Whether these agents act by releasing histamine and/or serotonin from 
mast cells or other cells should not be overlooked; neither should the generally 
accepted fact that almost any kind of cell injury will provoke release of histamine 
be overlooked. The relations of histamine and of serotonin to vasomotion are very 
intimately associated with capillary permeability.
H istam in ergic  N eu r a l  A ction
The action of histamine as a vasodilator is said to parallel that of cholinergic, 
parasympathetic nervous stimuli, while the action of epinephrine, or its deriva­
tives, A-40 and aludrine (293), as a vasoconstrictor is held to parallel that of adr­
energic, sympathetic nervous stimuli. Vasodilation is believed to be caused by a 
neural mechanism (31) and apparently to spread by antidromic or axon reflex 
(492, 648). Nevertheless, Uvnas (599) points out that the available experimental 
evidence indicates that "sympathetic vasodilator fibers are exclusively cholinergic" 
and are probably limited in effect to skeletal muscles and, possibly, to the coronary 
vessels, but that there is very little evidence indicating effectiveness of sympathetic 
vasodilator nerves to the skin of the dog's ear or to the intestines in this animal.
The world is indebted to Claude Bernard for the discovery in 1851 of vaso­
constrictor, and later of vasodilator, innervation in the rabbit (31). However, the 
mechanism of neural vasodilation as it affects the capillaries is not as well under­
stood as is vasodilation. The vasoconstrictor neurons all belong to the sympathetic 
nervous system, while vasodilation is accomplished chiefly by neurons from the 
parasympathetic, but also by fibers from the sympathetic and somatic sensory 
systems (31). Ample histamine occurs within the sheaths of these nerves; as much 
as 100 ug/g histamine dihydrochloride has been found in the sympathetic, splenic 
postganglionic nerves in the ox (608). However, von Euler (608) is not convinced 
that this histamine "serves as a mediator of nerve effects" on smooth muscle. Thus, 
the question of the presence of histaminergic nerves in mammals is far from being 
settled.
The muscularly walled arterioles are surprisingly well supplied with both vaso­
dilator and vasoconstrictor efferent autonomic nerve fibers (235), a fact which 
appears to indicate that neural control of vasomotion is limited to vessels having 
smooth muscle in the walls (649) either forming the tunica media or occurring as 
thin bundles or, possibly, as single cells. Since Zweifach (647) observed muscle 
in the wall of arterioles, precapillary arterioles, and a-v bridges, but found con­
tractile perivascular elements conspicuously absent in true capillaries in the
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mesentery of the mouse, it appears that the smooth muscle in these structures 
may be subject to autonomic stimulation but that this form of stimulation prob­
ably is incapable of affecting the true capillaries directly. Nevertheless, control 
of the diameter of the precapillary segments of the arteriole affects the diameter 
of the capillaries by regulating the amount and head-pressure of the blood entering 
them.
The neuromuscular mechanism suggests an explanation by which non-histamine- 
induced hyperemia of dermal areas, such as blushing, is effected. However, the 
probability of "central antidromic impulses" and of "  'nicotinic' action of acetyl­
choline" playing a part in blushing and in certain other instances of vasodilation 
has been seriously considered (492). Nevertheless, von Euler (608) states that his 
and Astrom's experiments involving stimulation of the ileum of guinea pigs through 
rather long (7-8 cm) pieces of splenic nerve from the ox indicate that the trans­
mission of neural stimuli is through release of histamine. Several other investi­
gators also hold that a chemical mediator, such as histamine, is involved in neural 
stimulation (429), while others suggest that enervation affects capillary sensitivity 
to histamine in a manner which is not completely understood (47). If this is the 
case in the normal animal, it would appear that vasodilation is generally effected 
by release of histamine. However, other writers indicate that histamine alone or 
adenylic acid alone could cause capillary dilation, for histamine causes arteriolar 
dilation in the dog, monkey, and man, while adenylic acid, like histamine, is 
released by tissue damage and also causes arteriolar dilation (31). Other writers 
discourage this idea by holding that in vasodilation, histamine has a direct action 
on the true capillaries, but that it dilates arterioles "indirectly through the axon 
reflex" (241). Tonutti (581) suggests that hormones may condition the tissue's 
reactivity potential to an irritant, while Boyd (70) indicates that still others 
believe that although histamine dilates capillaries it contracts arterioles. This 
last conclusion is open to discussion, for investigators apparently agree that 
although perfusion of the vessels in excised structures commonly produces arterio­
lar contraction as opposed to dilation in intact animals (47) it probably never has 
an opposite vasomoter effect on capillaries, certainly not on non-muscular, or 
true, capillaries.
Feldberg, 1955, suggests that one effect of large dosage of histamine may be 
neuromuscular block, but he does not state whether or not this neural effect is 
related directly to increased capillary permeability. However, he holds that the 
muscular weakness or paralysis of rats and cats following injection of large doses 
of either histamine or of histamine liberators, such as compound 48/80, may be 
entirely accounted for by the injected or released histamine producing either a 
neuromuscular block or affecting the muscle directly with the result that stimula­
tion of the motor nerve becomes ineffective (569). Feldberg, 1956, states that the
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muscular weakness and paralysis seen in rats after administration of a heavy dose 
of compound 48/80 "is certainly due to neuromuscular block" (569). The results 
of these experiments in producing muscular weakness by injecting the histamine- 
releasing compound 48/80 are very significant in that they indicate that mast 
cells are the chief source of the histamine since mast cells are fairly numerous in 
the internal perimysium of skeletal muscle in hamsters, and compound 48/80 is 
considered to be almost, if not quite, specific for the release of histamine from 
mast cells (399, 402, 474, 476).
Dale, 1910, 1911, found that intravenous injection of histamine depressed blood 
pressure profoundly in monkeys, dogs, cats, and fowl and that this result was 
caused by the primary action of the histamine independently of "the integrity 
of the sympathetic nervous system" (47).
A novel approach to this general problem was made by Barany and Nordqvist, 
1949, who found that nerve block caused by an histaminolytic or typical local 
anesthetics, such as procaine, could be removed by a histamine solution. They 
also found that when histamine was added to the solution containing a blocking 
agent, such as procaine, the property of the local anesthetic was lost (370). This 
antagonism between local anesthetics and histamine suggested to Martin (370) 
that since "all histaminolytic agents are local anesthetics" there is the probability 
that by use of Barany and Nordqvist's technique for nerve block it should be 
practical to correlate the action of local anesthetics with their antihistaminic 
power.
E p in eph r in e
Vasodilation results from intravenous infusion of epinephrine (547, 619) as 
well as from histamine. Epinephrine, unlike norepinephrine, "within the physio­
logical range" has an over-all vasodilator effect and causes increased blood pressure 
by increasing the output of the heart (616). The spanchnic and peripheral blood 
vessels may be powerfully constricted following intravenous injections of epine­
phrine, which acts upon the muscular layer in the vascular wall in proportion to 
its thickness. Consequently, the arteries are more strongly contracted than the 
terminal arterioles (547). Local injections of epinephrine produce local vaso­
constriction; while intravenous injection of epinephrine into normal animals 
produces a sharp, though not sustained, rise in blood pressure and an increased 
amplitude in heart beat, while in vagotomized dogs the blood pressure may exceed 
300 mm of mercury (547).
Staub, 1946, attributed the vasodilation following intravenous administration of 
epinephrine to the effects of histamine liberated by the epinephrine, since he 
observed a decidedly increased rise in plasma histamine (619). Whelan (619) 
observed that there was pronounced vasodilation in the forearm, which was fol­
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lowed by a sustained, increased flow subsequent to intravenous injection of epi­
nephrine into a human subject. He attributed this sustained flow to the appearance 
in the forearm of "some non-histamine, dilator substance from a site of release 
elsewhere in the body" since he obtained no increase in plasma histamine in the 
forearm by injecting epinephrine into the brachial artery.
The reported variable, often contradictory, effects of epinephrine on vascular 
structures is not as easily explained as may be imagined, for serotonin, histamine, 
acetylcholine, and epinephrine each constricted the isolated carotid arteries of 
swine. Epinephrine not only constricted the walls of the carotid arteries but also 
constricted the vasa vasorum of these arteries. However, neither epinephrine nor 
histamine was able to cause constriction of the vasa vasorum of coronary arteries 
of either man or swine, but acetylocholine readily caused them to constrict (542).
H istam inic  E ffec t s
Notwithstanding the fact that there are many agents and conditions capable 
of causing vasomotion, the most important single point to be discussed at this 
time pertains to histamine-produced hyperemia and the concomitant increase 
in capillary permeability, which may be local or extensive, and which may involve 
the entire structure or body. A disturbing factor in discussing histaminic effects is 
that it is appearent from the work of Benditt and his colleagues (43, 334, 493) that 
in an undetermined number of instances effects due to activity of serotonin or to 
the combined effects of this substance and histamine may have been erroneously 
credited to histamine, or vice versa. It has unquestionably been established that 
histamine can cause increased capillary permeability; whether it acts directly by 
dilating the capillaries or indirectly by constricting the arterioles and venules or 
acts on all structures of the capillary bed simultaneously has not been definitely 
settled. Rocha e Silva (485) carries the idea much further by stating that histamine 
not only constricts the small arterioles and venules, but also dilates the capillaries 
and increases their permeability, and that histamine is the only substance which 
has been shown to be capable of thus effecting dilation and increase in permeability 
of blood capillaries. He supports this idea by pointing out that irritating, toxic, 
inflammatory, and other agents which induce increased "capillary activity" 
do so chiefly by causing release of histamine. Irrespective of whatever time may 
prove concerning the relative and actual values of serotonin and histamine as 
edema-producing agents, the earliest published work on this function of serotonin 
appears to be that of Rocha e Silva (485) and Benditt and his co-workers (43, 493).
It has been suggested that changes in capillary permeability may be effected 
without producing a readily detectable change in the capillary wall. A possible 
example of this effect may be attributed to changes in the protein film covering the 
endothelial surface (647) and in the consistency of the endothelial cement sub­
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stance and surface film brought about by the "spreading substance" secreted by 
mast cells (380) or hyaluronidase (18, 148). Lewis', 1927, tenet that chemical and 
physical changes in the consistency of the capillary wall are essential for increased 
capillary permeability (492) strengthens this point of view.
Although histamine is a powerful vasodilator (619), there is a considerable 
amount of evidence indicating that it, probably aided by other agents including 
other mast cell products, also induces physicochemical changes in the components 
of the capillary wall (13, 380, 649) which, acting in conjunction with the increased 
volume of blood and possibly various other factors (18, 20, 21, 59, 492), is capable 
of profoundly increasing capillary permeability.
Histamine has been found to stimulate endothelial cells to phagocytize foreign 
lipoid, cholesteremic, and other materials, and it has been shown that this phago­
cytosis is prevented by antihistamines (13). Heinlein, 1935, holds that histamine 
causes endothelial cells to swell and subsequently palisade or even to become de­
tached (13).
Various investigators hold that X  irradiation increases capillary permeability, 
but they are not agreed on the mode of its operation in causing the increased 
permeability. Dahl, 1937, thinks that although there is no injury to the endothe­
lium, irradiation injures cells in the extravascular tissues, causing them to liberate 
the histamine which in turn causes the increased capillary permeability; Elfskind, 
1940, maintains that X  irradiation causes endothelial nuclei to swell, roundup, 
and lose their nucleoli (13). Similar conditions often prevail in instances of patho­
logically increased capillary permeability. That X  irradiation, especially if filters 
to prevent it are not used, produces capillary dilation in the skin was known to the 
early radiologists, who employed the "skin erythema dose" (S E D) as a base for 
reckoning dosage.
These observations and conclusions strongly indicate that released histamine 
causes capillary injury and concomitantly increased permeability, while the well- 
known tendency of mast cells to aggregate along small blood vessels and capil­
laries apparently indicates mast cells as the most likely source of this histamine. 
However, it is fairly evident that the mature mast cells (Type II) in the neigh­
boring connective tissue are the source of most of this histamine rather than those 
adjacent to the blood vessel, which are chiefly immature (Type I) cells (472).
There is a considerable amount of evidence strongly indicating that death or 
injury of any cell, or even mild disturbance of some cells, will cause or evoke 
release of histamine. Nevertheless, it is only comparatively recently that many 
of the more obscure instances in which histamine is released have been associated 
with increased capillary dilation and permeability. For instance, erythema, or 
redness of the skin, has been recognized as a hyperemia for many years (147), but 
the more modern clinicians and investigators usually attribute this condition to
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such causes as irritation or photochemical reaction. Despite the weight of evidence 
indicating the significance of histamine as an instigator of vasodilation and 
increased capillary permeability, this idea is modified or rejected in part or entirely 
by certain investigators.
Analysis of the over-all problem of the relation of histamine to hyperemia and 
increased capillary permeability is extremely complicated under normal physio­
logical conditions and is further complicated by experimental procedures, "disease 
states" (640), including such conditions as factitial urticaria (492), or dermo- 
graphia, and pathological conditions, because of the likelihood of multiple factors 
being involved.
D iv e r s e  R elations of H istam in e
Histamine causes marked contraction of intestinal and uterine smooth muscle 
of the guinea pig (47). An isolated piece of guinea pig's uterus reacted by contract­
ing when placed in 1:250,000,000 histamine in Ringer's solution. Histamine 
also caused contraction of excised pieces of uterus of the dog and rabbit, but had 
highly variable effects on the uterus of mice, while it usually inhibited contraction 
of excised pieces of rat uteri (47).
Histamine is a potent vasodilator of intact blood vessels (619) but, as described 
below, perfusion with it usually causes the blood vessels in excised structures to 
constrict. However, that histamine plays an important part in vasodilation fol­
lowing exposure to certain adverse conditions, including immersion of fingers or 
hand in cold water, temporary arrest of delimited circulation, exercise, and epi­
nephrine infusion of the human antebrachium, "is in some doubt" (619). Neverthe­
less, Code (108) holds that "stimulation of gastric secretion is a function of hista­
mine", and the work of others (47, 229) supports this view. Since a sustained 
increase in glandular secretion is effected through hyperemia, and histamine is 
known to be a potent agent in causing vasodilation and increased capillary perme­
ability (108), the ability of this amine to cause increased volume and acid content 
of gastric juice should primarily be attributed to histamine-produced hyperemia. 
The fact that investigators have shown that a powerful histamine releaser, such 
as compound 48/80, when injected subcutaneously into dogs or intravenously into 
cats is followed consistently "by the secretion of large quantities of highly acid 
gastric juice" supports the contention that increasing secretion of acid gastric 
juice, by "increasing the blood supply of the gastric glands", is a function of 
histamine (108).
Several investigators have made a point of the distribution of mast cells in the 
wall, especially in the adventitia, of the aorta and great veins (564) and of their 
characteristic of aggregating around ("cuffing"), or aligning themselves along, 
small vessels and capillaries (263, 392, 472, 473, 621). The presence of mast cells,
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which often form a perivascular sheath of immature, non-metachromatic mast 
cells (type I of Riley (472)) around muscular walled-arterioles and true capillaries 
(472, 473), and of numerous mature metachromatically staining mast cells (type 
II of Riley (472)) scattered throughout the loose connective tissue farther away 
from the blood vessels, appears to assure an adequate supply of histamine for 
unlimited, directly histamine-produced vasodilation, or for transfer of stimuli 
from vasodilator nerves (31).
Since, as has been stressed repeatedly in this review, mast cells are an important 
source of histamine, one apparently would be justified in assuming that these mast 
cells are an important source of the histamine, which undoubtedly plays a signifi­
cant part in vasodilation in general, wherever they occur in connection with blood 
vessels and that this significance is related to the density of the mast cell popula­
tion in the adventitia and neighboring connective tissue.
The effects of histamine and its antagonists on the normal terminal vascular 
structures and their functions bear a fairly definite relation to the architecture of 
the small blood vessels and may also involve the lymphatics. The tone and response 
of muscle tissue in the wall of arterioles, precapillaries, a-v bridges, and the dila­
tion and contraction of the true capillaries are essential to maintenance of the 
blood supply demanded by the condition of the tissues involved (647). These con­
ditions in normal animals vary from the basal, or resting, level of tissue activity, 
in which the contracted arterioles, precapillaries, and a-v bridges carry practically 
all the arterial blood directly to the prevenules, while the true capillaries are vir­
tually empty and may even be collapsed, to the hyperemic state in which the 
arterioles and a-v bridges are dilated and the true capillaries may all be greatly 
distended with blood (647).
M echanics of C a p il la r y  R espo n se
It is extremely difficult to explain the mechanics of changes in capillary permea­
bility since investigators are not in agreement as to the structure of the capillary 
wall (13, 647, 649), particularly of the endothelial membrane (13, 377, 607, 647, 
649), or the significance of chemical and physical changes in the luminal adsorbed 
protein film and/or in the perivascular connective tissue (13, 20, 148, 220, 327, 
380, 648).
Changes in capillary permeability usually result from changes not only in the 
capillary wall, which probably includes reticular and elastic fibers and collagen 
(13), but may also involve all entities forming the structure of the hematoparen- 
chymal barrier. This may include changes in the adsorbed protein film covering 
the luminal surface of the endothelium (380, 647, 649), probably in the basement 
membrane (13) and the endothelial cells themselves (13), and the consistency 
(380) and porosity (13, 467, 647, 648, 649) of the endothelial intercellular cement
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substance and in the pericapillary adnexa. The pericapillary adnexa, which in­
cludes elastic, fibrous, and collagenous connective tissues, part of which is or­
ganized to form the "pericapillary sheath", and the amorphous connective tissue 
ground substance containing hyaluronic acid (20, 148, 220, 327) and collagen 
(231, 316), forms probably the most important part of the blood-tissue barrier 
(550), the endothelial membrane serving chiefly as the "skeletal framework" of 
this barrier (649). This idea is carried much further by Duran-Reynals, 1947, 
who believes that capillary permeability is regulated by hyaluronidase, which is 
very important in controlling the permeability of the ground substance (148, 220, 
327), while Chambers and Zweifach, 1947, apparently think that the action of 
hyaluronidase causes capillary fragility (13). Drinker, 1927, presumably as a result 
of perfusing the web of the foot with extracts of pituitary gland and horse serum, 
concluded that a hormone is present in frog blood which is capable of restoring 
and maintaining normal capillary permeability in capillaries previously made 
permeable to colloids (329).
Hyaluronidase evidently plays a very important, although indirect, role in con­
trolling capillary permeability by altering the viscosity of the hyaluronic acid in 
the pericapillary connective tissue and its ground substance. The idea that the 
anti-inflammatory effect of adrenocortical hormones is mediated chiefly through 
the activity of these hormones in increasing capillary resistance and the conse­
quent decrease in capillary permeability (327) sheds some light on the relation of 
viscosity changes in hyaluronic acid to permeability changes in the capillaries. 
Other work (220) showing that the anti-inflammatory action of certain adrenocor­
tical substances affects hyaluronic acid by increasing "the hyaluronidase inhibitor 
levels" in the blood serum adds to transportation complications but does not mili­
tate against the concept of cortical control of hyaluronidase. Five of 36 adrenalo- 
cortical hormones (1 mg/100 g body weight/day for 3 days), including cortisone 
acetate, increased capillary resistance, as shown by the abdominal skin test, in 
rats previously accustomed to handling 50 to 60 cm Hg over that of control ani­
mals (327). In the light of results obtained by other investigators (220), this in­
crease in capillary resistance should be attributed chiefly to the potency 
of cortisone and certain other adrenalocortical hormones in suppressing activity 
of hyaluronidase and consequent increase in viscosity of the hyaluronic acid.
Sommers (550) stresses the significance of normally intact basement membranes 
and connective tissue ground substance and points out that localized dissolution 
of basement membranes sometimes precedes parenchymal atrophy of aging or­
gans. Although his emphasis is upon organs, it is evident that capillary permeabil­
ity changes are the motivating factors.
Kisch, 1955, attaches great significance to the wall and adnexa of the capillary 
in regard to the complexity of its structure and relation to permeability changes
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in capillaries as revealed by the electron microscope. He regularly observed an 
unidentified substance between the capillary wall and its sheaths. He makes 
various comments on the complexity of capillary structure and stresses the sig­
nificance of changes occurring in the capillary wall under various conditions, 
especially as seen in ascorbic acid deficiency (649).
An important point in the mechanics of capillary permeability pertains to the 
physical state of the capillary wall which in true capillaries of the mouse's mesen­
tery is composed of elastic endothelium that "remains the sole contractile element" 
(647) and in the distended state exhibits stigmata, or perforations (467, 647). 
Thus, since the wall of the true capillary is elastic and porous, increased blood 
volume in the arteriolar trunk and the related increase in capillary dilation may 
increase leakage of protein molecules at a rate much higher than would be sug­
gested by the actual increase in diameter of the capillary. Vasomotion of the true 
capillaries in both normal and inflammatory conditions could be effected without 
any direct influence being applied to the true capillaries, other than the elasticity 
of the endothelial walls which would function only in producing a certain degree 
of tonus in the capillary, for any vasomotion affecting the a-v bridge-precapillary- 
arteriolar region of the artery would be immediately transferred as a blood pressure 
change in the true capillaries. Thus, inhibition of the muscular region of a terminal 
arteriolar structure would cause dilation and, if sustained, an increase in capillary 
blood pressure which would favor exudation. These relations could account for 
Menkin's (387) having found the available data to indicate that in inflammation 
or simple hyperemia, capillary dilation is accompanied by increased capillary 
pressure. Landis, 1934, also held that arteriolar dilation is responsible for "the rise 
in capillary pressure in hyperemic conditions" (387).
Various writers have pointed out that increased capillary permeability is com­
monly associated with dilation in a large number of capillaries, and that capillary 
permeability can be increased until any colloid will pass through the wall, but 
that some dilation may occur without any perceptible increase in permeability, 
while a high degree of permeability may be attained without appreciable dilation 
of the capillaries (329).
E x per im en t a l  P e r m e a b il it y  C h anges
Changes produced experimentally in capillary permeability may be expected 
primarily to involve the entire terminal arteriolar structure, both the muscular 
part and the muscle-free part, which comprises the true capillaries.
Hyperemia is essential, but the work of Lewis, 1927, strongly indicates that, 
in addition to increased blood flow, it is necessary that some sort of a physicochemi- 
cal ("qualitative") change take place in the capillary wall before its permeability, 
especially to proteins, can be markedly increased. He found that applying suction
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(90 mm Hg negative pressure) to sensitized human skin (red line) and that in­
creasing capillary pressure by interrupting venous return failed to promote wheal- 
ing and that 50 mm Hg positive pressure on the sensitized skin failed to prevent 
formation of wheals (492).
Capillaries are extremely sensitive to environmental changes, as well as to 
irritation or actual injury, as is indicated by altered permeability of the walls of 
disturbed capillaries. The amount or extent of disturbance necessary to provoke 
an increase or a decrease in capillary permeability is so small that it does not need 
to produce a physical change in the involved capillaries. Zweifach (647, 648) 
found that merely stroking the peritoneum of the mesentery with a microneedle 
produced a pronounced increase in permeability of nearby, but untouched, capil­
laries in the mesentery of mice. Hyman and Chambers offer another approach by 
having shown that capillary permeability can be readily decreased without any 
detectable decrease in diameter or other physical change in the capillaries of 
rabbit. They attribut ed this decrease in permeability to a change in the endothelial 
cells of the capillaries and state that this condition may be induced by extremely 
weak solutions of adrenocortical hormone (607). Contrarily, McGovern's (380) 
"spreading substance", which increases capillary permeability and which he sug­
gests is secreted by mast cells, would be expected to increase endothelial permea­
bility without causing perceptible change in capillary diameter, by altering the 
consistency of the intercellular cement and endothelial covering film, provided 
its actions were not augmented by released histamine.
N ormal C a p il la r ie s
These observations suggest that it would be advisable to consider some of the 
points concerning permeability changes of normal capillaries at this time. Under 
normal conditions maintenance permeability, which may be considered primarily 
as supplying the normal amount of transudate, appears to be a function of the 
a-v bridge, with possible contributions from the arteriole and precapillary, while 
the true capillaries are primarily collapsed or otherwise inactive most of the time 
(329, 647, 648). Under conditions of normal maintenance a higher level of per­
meability of controlled duration is probably induced for the purpose of permitting 
passage of proteins, other substances, and added amounts of serum as needed by 
the tissues. Conceivably, this cyclic process may be initiated by an infinitesimal 
amount of mast cell secretion, which may be released by dialysis rather than by 
cytolysis of the involved mast cells or possibly by neural stimuli.
Renkin (467) points out that the normal endothelial cell, like many other kinds 
of normal cells having diverse origins and functions, has a much higher degree of 
permeability to lipid-soluble molecules than to lipid-insoluble molecules; and he 
suggests that the lipid insoluble molecules may be largely restricted to pass out of 
the capillaries through the stomata. He (467) suggests that the freedom with which
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lipid-soluble molecules, including oxygen and carbon dioxide, permeate the capil­
lary wall may be the result of increased permeability of the endothelial cells them­
selves rather than involving a change in either the intercellular cement or the stig­
mata. This application of differential rate of dialysis through the endothelium, 
which is further complicated by changes that may occur in the adsorbed protein 
membrane covering the endothelium, the endothelial membrane itself, and/or 
the pericapillary connective tissue and its ground substance, affords a mechanism 
which is capable of drastically changing the rate of capillary dialysis and the com­
position of the dialysate.
Landis, 1934, has shown that injury to a capillary may increase the amount of 
escaping fluid as much as 7 times the normal amount (377). This leakage is the 
result of vasodilation which causes dilation of the capillary pores (377, 467, 647, 
648). Estimates based on the known size of particles which passed through gave 
maximum values around 38 Angstrom units for the diameter of the pores in normal 
capillaries and up to 200 Angstrom units diameter of the pores in dilated capillaries 
resulting from injury (377).
It should be pointed out at this time that the presence of capillary stomata is 
not universally accepted, for some investigators hold that capillary walls do not 
have actual stomata or any type of preformed openings designed to permit passage 
of materials into the intercapillary areas (235, 329); others believe that stomata 
are only temporarily formed in the cement substance and basement membrane by 
liquefaction; some doubt the presence of a basement membrane in any blood vessel 
(13,329).
The ground substance of the connective tissue in which the capillaries are em­
bedded normally has a gell-like or slimy, viscous consistency (20, 148), but when 
the capillary is stimulated with microneedles the endothelium loses its elasticity, 
becomes sticky, and the connective tissue ground substance becomes increasingly 
liquid, thus greatly favoring the spread of exudate into the tissues. This process 
occurs in the mesentery of the mouse, cat, and frog (648). Other investigators have 
demonstrated a similar reaction in exteriorized mesentery of the frog (329), rat, 
dog, and cat (648).
The blood vessels of ascorbic acid-deficient guinea pigs formed petechiae during 
experimental trauma much more readily than those in normal animals. In at least 
90 per cent of the instances, the escape of the formed blood elements was through 
the collecting venules in the capillary field; most often through a 'tricornered' tear, 
but in some instances through the increased porosity of the venular wall (339).
M echanical I rritation
Extremely delimited areas of irritation or injury (10-15 n) are known to release 
histamine and to produce capillary dilation with increased capillary permeability 
(647, 648). Zweifach (648) showed in a film that gentle irritation, produced by
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tapping the wall of a capillary with a microneedle, caused dilation of the capillary 
with such marked increase in the diameter of the so-called stigmata, or capillary 
pores (377), that they consistently trapped erythrocytes. In one instance the film 
shows a capillary with an erythrocyte "being extruded through a tiny opening and 
pinched into two parts". Since any injury may be expected to release endogenous 
histamine, this would be the logical explanation of the increased capillary permea­
bility, but Zweifach (648) was unable to obtain any evidence "to establish unequi­
vocally the participation of particular substances, such as histamine, leukotaxine, 
etc." in these vascular reactions.
Zweifach (648), by injecting graphite, showed that the surface of endothelial 
cells normally is not sticky, and he observed no tendency for platelets to adhere to 
the walls of arterioles or to each other in otherwise normal mice. However, irrita­
tion with microneedles, presumably by releasing histamine, heparin, and, possibly, 
McGovern's (380) "spreading substance" from mast cells, initiated vascular dila­
tion and the stickiness with the result that carbon particles, as well as platelets 
and leukocytes, adhered to the endothelium. Even the slightest injury, such as 
that caused by gently stroking the mesothelium with microneedles without touch­
ing the capillary, produced stickiness within the capillary just proximad to the 
site of irritation, while more severe irritation of the vessel caused stickiness distad 
to the site of the injury. When the immediate vicinity of a terminal arteriole was 
intensely stimulated mechanically by injury or gently rubbing with the micro­
needles for 30 to 40 seconds, blood platelets accumulated on the endothelium and 
"adhered to one another forming long strings or chains" within the arteriole at the 
site of irritation (648).
Exogenous H istam in e
Intradermal injection, topical application or other means of exposing tissues to 
histamine may provoke capillary reaction and, usually, increased permeability of 
the walls of the involved capillaries. Investigators in 1910 and 1911 showed that 
histamine injected intravenously into anesthetized fowl, cats, dogs, and monkeys 
profoundly reduced blood pressure (47). Dale and co-workers, 1910, 1918, found 
that vasoconstriction resulted when excised structures of the cat were perfused 
with histamine, but if erythrocytes or epinephrine was added to the heparin solu­
tion before perfusion, vasodilation was produced in these structures. Histamine 
perfusion of these structures in the intact, control cats also caused vasodilation 
(47). Florey and Carlton, 1926, injected histamine into the saphenous vein of 
anesthetized cats and observed dilation of mesenteric capillaries and venules and 
opening up of collapsed mesenteric capillaries. Removal of a piece of the mesentery 
was followed by constriction of its venules. When pituitrin was applied to the 
omentum having capillaries fully dilated by the histamine, the capillaries definitely
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constricted (47). Similar effects of histamine were observed by Rich, 1921, who 
found that injection of histamine produced local dilation of small arterioles, capil­
laries, and venules in the mesentery of anesthetized cats. He also observed "new 
capillaries" open up in the omentum as a result of the injected histamine (47).
Topical application of weak solutions of histamine has been shown to be very 
effective in causing vasodilation and increased permeability. Carrier, 1922, dem­
onstrated dilation of the capillaries in normal human subjects with accelerated 
capillary flow accompanied by edema following applications of histamine diluted 
1:1000, 1:5,000, and 1:10,000 to the base of the finger nail (47). Feldberg, 1927, 
and Flatow, 1929, applied histamine to the rabbit's ear and observed dilation and 
opening up of new capillaries (47).
E ndogenous H istam in e
Rocha e Silva, 1953, states that many observers have shown that in sensitized 
animals antigen injury provokes platelet response in capillaries similar to that 
following microtrauma and that this reaction apparently is connected with libera­
tion of histamine and heparin from hepatic cells in the dog (648). Rocha e Silva's 
connecting the above effects of microtrauma and antigen injury with liberation of 
histamine appears to be very logical, but does not preclude the possibility of 
adenylic acid, which is released by tissue injury and causes arteriolar dilation (31), 
playing a part. However, with an abundance of mast cells within the adjacent 
connective tissue and the presence of blood platelets, which Dale, 1956, holds con­
tain great amounts of histamine in the rabbit, but none in the horse (60), it would 
hardly be necessary to look to the liver as the source of the active histamine and 
heparin. Speirs (551) extends and in part supports Rocha e Silva's tenet by point­
ing out that antigen introduced into sensitized animals, especially when it produces 
anaphylactic reactions, may provoke release of several substances, including 
heparin, histamine, hyaluronidase, possibly choline, and other active substances, 
to which many of the observed symptoms may be attributed.
Lewis and his colleagues, 1927, neatly showed that the triple response and wheal- 
ing are directly dependent on increased capillary permeability. These investigators 
found that if, after arresting the circulation by compression, the mechanical stimu­
lus was applied to the skin, whealing failed to develop as long as the circulation 
was prevented, but as soon as the blood was allowed to flow, the triple response 
immediately appeared (492).
Reference has repeatedly been made in this review to various types of experi­
ments which show that injury, irritation, or almost any form of disturbance of 
living tissue will provoke release of histamine, capillary dilation, and increased 
capillary permeability in laboratory animals and man. However, the fact that in 
many ways endogenous and exogenous histamine produce similar or even identical
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results, as in so-called serous inflammation (13) and whealing (492), raises a doubt 
as to the practicability of trying to consider exogenous and endogenous histamine 
separately. This distinction usually is readily made in experimental work, but 
when it is applied to insect bites and stings or to contact with poisonous or allergic 
plants or other agents, it is often difficult to determine whether the offensive 
histamine was introduced into the tissues or released within the tissues by the 
introduced substance, such as formic acid in bee stings. The demonstration of 
considerable amounts of histamine in nettles, lambs quarter, tomatoes, spinach 
(0.5 mg/g in growing seeds, up to 1.34 mg/g in flowers of over-wintered plants) 
and other plants (186) may add to this confusion.
I nflammatory P ro cesses
The universal presence of increased capillary permeability in inflammed tissues 
and in those undergoing amyloid degeneration is attributed by Lewis, 1927, to 
the presence of histamine and/or its related H-substance (329). Incidentally, 
Lewis' H-substance is now known to be histamine (492). That histamine is capable 
of increasing capillary permeability is well established, and it has been shown that 
serotonin released from mast cells is very potent as an edema-producing agent 
(330).
There are certain factors which militate against presenting clearcut, indubitable 
evidence to show to what extent mast cells are involved as a source of the hista­
mine, serotonin, and/or other substances concerned with hyperemia, increased 
capillary permeability, local tissue reaction, and consequent changes occurring in 
inflammatory processes. Nevertheless, there is ample proof that histamine, either 
endogenous or exogenous, will provoke hyperemia and increased capillary per­
meability; that these two phenomena play a significant part in inflammatory proc­
esses and that mast cells contain relatively large quantities of releasable histamine 
and are almost universally present in the connective tissues of normal structures 
(402, 617) and commonly occur at the site of local inflammation (361, 377). It 
has repeatedly been shown that intradermal injection of a minute (1 to 1 or 2 
million parts (492)) concentration of histamine speedily produces the triple response 
(1.5-3 minutes (492)) and the 4 cardinal signs of inflammation (237, 492). Never­
theless, Ungar, 1953, holds that this reaction does not prove that histamine is the 
only mediator of the inflammatory reaction (285), but it might be attributed to 
"a  more fundamental process" of which histamine release could be merely inci­
dental (595).
Several concepts of the relation of connective tissue, including its active fibro­
blasts, mast cell-content, and ground substance, to the onset and support of in­
flammatory processes lend significance to the importance of the part played by 
hyaluronic acid in particular and to the products of mucopolysaccharide metabo­
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lism in general in these processes. The opinion has been expressed that loose con­
nective tissue is a primary site of inflammation (256), the chief site of mast cell 
formation (392, 472) and, following even the least unfavorable type of stimulation, 
very likely is instrumental in causing the mast cells to release their granules as a 
measure of protection (256).
Increasing interest is being shown in the part played by hyaluronic acid, which 
is held to be derived from mast cells (23), in maintaining normal capillary per­
meability by degradation of this mucopolysaccharide. Recent work shows that the 
mode of action of cortisone and certain other antiphlogistic adrenalocortical hor­
mones is to produce increased capillary resistance (327) which is effected chiefly by 
suppressing the activity of hyaluronidase (220). These and other observations on 
the vasomotor effects of histamine and serotonin and the significance of mast cells 
as the probable source of these substances certainly warrant further consideration.
C a pilla r y  D ilation
Celsus (25 B. C.-45 A. D.) clearly recognized the four cardinal signs of inflam­
mation (357) and, in the absence of any knowledge of capillaries, listed them as 
"rubor, calor, tumor, and dolor", a terminology and sequence of events which 
time has not altered (357, 361, 377). Both rubor (erythema) and calor (heat) are 
due to hyperemia; tumor (swelling) and dolor (pain) are the result of increased 
capillary permeability (357, 361, 377) and resultant pressure (492).
The physiological changes which local circulation undergoes in an inflamed 
area were recognized and stressed by Cohnheim, Samuel, and Virchow. Samuel in 
1873 recorded his belief that changes in the walls of these blood vessels gave origin 
to the exudate which forms the fluid in exudative edema (387). However, Cohn­
heim, 1866 and later, paved the way for further experimental interpretation of 
inflammatory processes (387) and edematous relations.
Ehrich (158) after briefly summarizing the theories on the mode of origin of 
inflammation from humeral to vascular and phagocytic concepts, supports the 
theory that inflammation may be regarded as "disturbance in homeostasis" pro­
voked, at least in part, by tissue injury and release of histamine. Lewis', 1924, 
1927, results support Ehrich's (158) conclusions by strongly indicating that ery­
thema following X  irradiation is caused by release of histamine within the skin; 
Ellinger, 1928, 1930, holds that ultraviolet and X  irradiations cause an increase 
in histamine in the skin by killing some cells and by decomposing histidine photo- 
chemically (317). Ehrich, 1953, also states that Roessle holds that instead of the 
vascular reaction being "an essential part of inflammation" it may be considered 
as an "auxilliary mechanism" having the function of accelerating removal of the 
cause of the inflammation (285).
Although Roessle's explanation is quite tenable, hyperemia and increased capil­
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lary permeability will probably remain the most significant characteristic for 
recognition of inflammatory processes. Ungar (594) in his plea for some measure 
of agreement on the definition of inflammation, stresses the idea that primarily 
inflammation is a vascular response, while Dorland (140) states that inflammation 
is characterized "histologically by hyperemia, stasis, changes in the blood and 
walls of the small vessels, and by various exudations".
M ast  C e l l  R elations
A number of pathologists have recorded the presence of mast cells in inflamma­
tion and state that they may be especially numerous during chronic inflammation 
(377). Many investigators have noted that the density of mast cell population is 
directly related to the proximity of small blood vessels and that this relation is 
commonly demonstrated by aggregations of mast cells around small vessels (392, 
472, 476). Whether this arrangement is a form of reciprocity in which the mast 
cells receive needed substances from the blood stream and the blood stream re­
ceives heparin, histamine, and/or other substances from the mast cells is interest­
ing speculation but, apparently, has not been given very much serious considera­
tion.
It has been observed that prolonged inflammatory conditions which are favor­
able for increasing the numbers ("infiltration") of lymphocytes and plasmacytes 
are also favorable for increasing the number of mast cells. Further observations on 
exudates suggested that whether the edema fluid will be favorable for mastocyto- 
genesis and the transformation of small lymphocytes into plasmacytes depends 
primarily upon its protein content. The protein content of the extravascular fluid 
is most commonly related to conditions favoring passage of the large protein 
molecules through capillary walls into a situation which detains the plasma 
protein, commonly by formation of a fibrin network, but allows a part of the 
plasma to pass on. These requirements are met in prolonged inflammation with 
the added advantage of the presence of abundant, similar materials released from 
cells, as in delimited necrosis, under similar circumstances of stasis. Thus, trans­
udates or edema fluid formed by stasis, such as in cardiac or renal edema, in which 
the fluid has the lowest protein content of all edema fluids (70) and, consequently, 
low specific gravity (377), is not favorable for either mastocytogenesis or plasma- 
cytogenesis.
The fixing and staining procedures used routinely by pathologists and many 
other students of inflammatory processes usually destroy the mast cell granules 
(344, 392, 492) and thus obliterate the most reliable characteristic for identifying 
them. The relations of these cells to inflammatory processes have been neglected 
to a surprising extent. Another point is that, although some investigators recog­
nized an increase in the number of mast cells and tissue damage, which was at-
CAPILLARY PERMEABILITY 25
tributed to "repeated episodes of necrosis", in chronic inflammatory processes 
(377) mast cells were often considered merely as a type of "infiltrating cell" and 
as having an unknown purpose (361, 377).
Stemmler, 1921, observed that the normal population of mast cells is reduced in 
acute inflammation, as well as in granulation tissue, but that the number increases 
"wherever mature tissue is being formed" (344). This observation supports the con­
tention that early in acute inflammatory processes the resident mast cell popula­
tion is decimated in response to the demand for, or otherwise provoked release of, 
histamine and that no new mast cells are formed until a sufficiently favorable 
exudate is provided, as is explained below.
Halpern (237) states that all the phenomena produced by injection of egg white 
"are borrowed by the typical inflammatory lesion". This statement is very signifi­
cant in support of the idea that mast cells play an important part in inflammation, 
for injection of egg white or ovomucin, especially into rats, provokes lysis of mast 
cells and liberates quantities of histamine by so doing (42, 238, 486, 503).
The observation that the mast cell population is reduced in acute inflammation 
(344, 361, 377), but increased in chronic inflammation, in which there is commonly 
an appreciable amount of tissue damage caused chiefly by "repeated episodes of 
necrosis" or alternating degenerative and proliferative changes (377), especially 
in allergic or rheumatic reactions (620), may be somewhat clarified by the follow­
ing explanation. The initiating agent depletes the resident mast cells of the normal 
tissue, thus releasing histamine, which is speedily followed by the sequence of 
hyperemia, increased capillary permeability, protein leakage, marked edema, and 
stasis, which stages are generally recognized and have been confirmed by us as 
being conducive to mastocytogenesis, as well as "invasion" by other exudate cells. 
As chronicity develops, vascularity and edema progressively decrease, while mast 
cells are observed to have increased in numbers (377). Apparently, the condition 
of stasis and early necrosis stimulates progenitor cell activity to salvage certain 
components from the exudate and store them as granules and in so doing these 
progenitor cells develop into mast cells. As the hyperemia, edema, and demand 
for histamine regress, the supply and increment of mast cells remains in excess of 
the demands made for histamine by the repeated episodes of proliferation and 
necrosis.
H istam in e  in  A l ler g y
Histamine unquestionably plays an important part in initiation, or as a con­
comitant, of all allergic reactions, but its mode of action as related to other factors 
is controversial. The significance of the mast cell in allergenic reactions is chiefly 
that it is a rich and readily available source of histamine, especially in the skin, 
where these cells doubtless play a very significant role in dermographism and
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general urticarial demonstrations. Several investigators have shown that mast 
cells are probably the chief source of the histamine which is generally conceded to 
be directly responsible for initiating local hyperemia resulting in formation of the 
welts, hives, wheals, et cetera, which may be diagnosed as urticaria in one or more 
of its many forms.
I nitiation  of H y p e r se n sit iv it y
Failure to control release, inactivation, or sudden release of histamine apparently 
constitutes the most important factor in allergic or hypersensitive reactions and 
anaphylaxis. Dragstedt in 1945 reviewed the literature on the evidence for and 
against histamine being related to anaphylaxis and concluded that histamine 
plays a significant part in anaphylactic reactions, but that the mechanism of its 
release is not understood (597). A number of writers subscribe to the idea that the 
cause of acute anaphylaxis is "the sudden liberation of histamine or histamine-like 
substances from the tissues as a result of the 'shocking' dose of antigen" (625). 
Schachter showed conclusively in 1953 that release of histamine "is a significant 
factor in the toxicology of acute anaphylactic reaction" in the rabbit (468). The 
suggestion that histamine is involved in most, if not all, reactions of substances 
provoking hyperergic inflammations is supported by Rocha e Silva's (484) state­
ment that the contraction of guinea pig ileum produced by a preparation of rat 
anaphylatoxin "is also due to release of histamine from the isolated organ". 
Schild (507) sets forth data to support his tenet that release of histamine plays 
about the same role in human allergic asthma as it does in anaphylaxis of guinea 
pigs. Contrarily, Code held in 1944 that histamine is not the fundamental factor 
in allergic reactions and in anaphylaxis and that liberation of histamine is merely 
incidental to cell damage, which is of primary importance in instigating these 
reactions (252). Eleven years later he (107) amplified this tenet somewhat by 
stating that, instead of the white cell elements containing most of the histamine, 
the major portion of it occurs in the serum which facilitates its activity. Urbach 
and Gottlieb (597) feel the assumption that the substances which are usually ac­
corded the role of instigator, such as acetocholine and histamine, are not the cause 
but the result of antigen-antibody reactions. Speirs (551) holds that the eosinophilia 
which follows antigen-antibody reactions apparently is not caused by histamine, 
heparin, hyaluronidase, or choline. Urbach and Gottlieb (597) point out that per 
se neither blood nor tissue eosinophilia is conclusive evidence that an allergy ex­
ists. They (597) add that allergies may be a result of increased stimulation of para­
sympathetic nerves and point to the fact that parasympathetic-stimulating drugs 
"favor allergization or tend to prolong an existing hypersensitiveness". Also, a 
diet low in ascorbic acid has been considered to be conducive to allergies in both 
man and mammals (597). Histamine is probably not the substance responsible
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for shock, even in animals injected with H -substance (41), and probably is not the 
primary factor in traumatic shock (252). Dragstedt, 1945, expresses the consensus 
by stating that although histamine is a definite factor in anaphylaxis, no one 
appears to understand the mechanism which releases it (597).
A ller g ic  R espo n se
Perhaps the most plausible concept of anaphylaxis is that suggested by Urbach 
and Gottlieb (597). They, citing the works of Code, 1944, Wendt, 1939, and others, 
reject the explanation that anaphylaxis is "the result of a simple histamine in­
toxication" as being inadequate and suggest that anaphylaxis is the result of a 
series of interactions of a number of biologically active substances of different 
types of tissue products such as choline, epinephrine, histamine, and others, which 
affect the chemical regulation of the autonomic effector organs and the autonomic 
nerves (597).
It is supposed, chiefly upon indirect or circumstantial evidence, that Lewis' 
"triple response" (characterized by a red line, flare, and wheal), insect bites, 
irritants, and various other forms of local damage to the skin, liberate histamine 
(41). Lewis, 1927, held that his triple response "is identical with the reaction re­
sulting from intradermal injection of histamine" which causes local dilation of 
capillaries and arterioles with escape of protein-rich fluid (597); Rothman (492) 
points out that there is now available sufficient evidence to show that Lewis' 
"H-substance is actually histamine". Riley (473) aptly attributes the ease with 
which this "triple response" may be elicited in urticaria pigmentosa skin lesions 
in man to the fact that lesions of this kind constitute a type of "shock organ" 
which is "rich in mast cells" and thus capable of releasing a quantity of histamine 
upon the least provocation. Contrarily, Perry (440) holds that the histamine 
responsible for the triple response does not come from mast cells. This statement 
would be rather difficult to prove or disprove experimentally, but in the light of 
the known mast cell content of histamine in human and other skin (18, 186, 402), 
it is open to considerable skepticism.
There is probably a definite disturbance in the water balance and in certain 
enzymic cycles during the course of allergic diseases, for there are inconsistent and 
noncharacteristic alterations in the chemical components of the blood, particularly 
with regard to amino acids, calcium, cholesterol, chlorides, magnesium, phos­
phorus, and potassium content (597). Rusk and his collaborators, 1939, found that 
the serum potassium values were definitely higher in urticaria (23.4 mg/100 ml), 
in acute asthmatic attacks (24.4 mg/100 ml) and in the asymptomatic period in 
bronchial asthma (23.6 mg/100 ml) than in healthy human subjects (19.5 mg/100 
ml). Although epinephrine produced relief in these patients, it did not significantly 
alter the serum potassium level (597). Various investigators have found the blood
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histamine level higher in asthmatics than in normal individuals (614), but as Rose, 
1954, points out, the release of histamine is not the sole cause of asthmatic symp­
toms (614).
H ista m in e  in  Shock
The part played by histamine in several types of shock is not clearly demon­
strated, and especially in man the course of shock is not constant, but may be 
strikingly diversified (485). In certain human cases lung emphysema, as in guinea 
pigs, liver congestion, which is common in dogs, or venous congestion caused by 
dilation of the right heart, as in the rabbit, may be pronounced conditions in 
anaphylaxis (485). Since shock is a condition of acute peripheral circulatory failure 
(140), there are grounds for suspecting that histamine is either associated with 
the cause of shock in certain types or with the effects of shock in those types not 
otherwise explained. Thus, histamine may be associated with, but possibly is not 
the cause of, primary shock, while it is conceivable that factors other than neural 
or histaminic may be responsible in certain types of shock. Briefly, whenever a 
sufficient amount of blood plasma is lost from the circulation, usually by pooling, 
hemorrhage, or transudation, shock supervenes (140).
Halpern (238) states that intraperitoneal administration of a histamine liberator 
(dextran (30 mg/100 g)) to adrenalectomized rats provoked severe dyspnea, 
prostration with acute vascular collapse, and death of all the animals within 20 
minutes; ovomucoid (1 mg N/100 g) produced similar symptoms, but the rats 
lived a maximum of 2 hours. Intraveous injection of these histamine liberators 
greatly increased their toxicity. Halpern (238) concluded that the basic and major 
disturbance produced by administration of dextran or ovomucoid is "damage of 
the small blood vessels, which is reflected by an increase in capillary permeability" 
resulting in formation of a characteristic edema having a high protein content and 
a severe hemoconcentration. He (238) further indicated that histaminic action 
was involved by finding that edema and almost all the symptoms caused by dex­
tran can be prevented in intact rats by injection of the synthetic antihistamine 
promethazine, or phenergan. Bennati and Patetta (44) found that benadryl pro­
tected animals against lethal histamine shock but not against peptone shock.
Glenn, Gilbert, and Drinker, 1943, found that experimental burns of the foot 
provoked escape into the tissues of quantities of plasma which approximated a 
third of the total volume of blood (377). Such conditions of shock certainly indicate 
the current concept of histaminic activity and probably involve heparin as well. 
However, the work of Rowley and Benditt (493) strongly indicates that serotonin 
plays an important part as a causative agent in cases of profound edema, especially 
if mast cell damage is involved as would be expected in extensive skin burns. In 
the case of the experimental burns of the foot, cutaneous and subcutaneous mast
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cells would be expected to release relatively large quantities of histamine and 
heparin. Incidentally, the fact that decreased coagulability of the blood is one of 
the functional effects of shock (377), suggests increased release of heparin, a fact 
which has been verified in dogs anesthetized with dial, vagotomized, and injected 
intravenously with peptone (27).
Histamine shock is held to differ from anaphylactic shock in the absence of the 
reduced body temperature, and the increased blood coagulation time, both of 
which are characteristic symptoms seen in anaphalactic shock (597). A marked 
increase in coagulation time was observed in 4 guinea pigs killed while in profound 
anaphylactic shock produced by horse serum (305). Also, it is stated that arginine 
prevents the lethal effects of administered histamine but not of anaphylactic shock, 
while heparin inhibits anaphylaxis but is incapable of inhibiting histamine shock 
(597).
Rocha e Silva, 1947, presents another complication by pointing out that in 
anaphylactoid conditions fibrinolysin releases histamine and heparin from cells 
(520), but it is not clear whether mast cells are included or not. Selye (520) points 
out that the various stresses alter the water balance, chiefly by disturbing the in­
tracellular protein-intercellular sodium relations, which is accompanied by potas­
sium and pH changes. Acidosis of transitory nature has been observed in both 
animals and man following a variety of systemic stressors, including anoxia, burns, 
electro-shock, 'gravity shock', and 'medical shock' (520). However, nothing is 
said about mast cells as a source of the histamine which is known to be released in 
relation to some of these conditions, especially burns (377), and the resultant in­
creased capillary permeability. Menkin (387) shows that, with few experimentally 
produced exceptions in dogs, similar changes take place in the inflammatory proc­
ess. Other investigators (344, 361, 377) have recorded concomitant changes in 
local mast cell populations, but neither mast cells nor metachromasia is listed in 
the index of either Selye's (520) or Menkin's (387) monograph.
Mongar and Schild, 1952, point out several ways in which the effects of anaphy­
laxis and certain simple chemical bases are similar in releasing histamine, but that 
their mode of effecting the release of histamine apparently differs (507); Reuse 
(468) apparently holds that anaphylaxis is due to release of histamine. Parrot, 
1942, and Mongar and Schild, 1955, hold that in anaphylaxis the release of hista­
mine is a process requiring energy and that this process may be blocked by various 
metabolic inhibitors, including iodoacetate or lack of oxygen (507). However, 
chemical releasers, such as acetylamine or compound 48/80, do not require pro­
vision of energy, but are activated by iodoacetate or the lack of oxygen, as shown 
by minced lung of guinea pigs in vitro (507).
Wilander (621) reports that he isolated sufficient amounts of heparin from the 
plasma of dogs in peptone shock to account for the incoagulability of the blood in
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anaphylactic or peptone shock and that protamine completely allayed the anti­
coagulant effect of the heparin in the dogs. He holds that during shock, the mast 
cells empty their granular contents into the blood, and he showed that blood 
clotting was not inhibited in hepatectomized dogs, but that shock plasma recovered 
after being passed through the isolated liver inhibited coagulation.
Antihistamine drugs operate by competing with histamine for the normal hista- 
mine-receptive sites and by this means prevent the appearance of histaminic 
effects (245). Such a simple explanation of histamine antagonism may hold for 
some, but not for all, histamine antagonists, for these substances are also histamine 
releasers and many of them, when used in concentrations sufficient to antagonize 
anaphylaxis of smooth muscle, independently produce a bronchoconstrictor action 
which reduces their effectiveness in treating bronchial asthma (507). Similar effects 
of antihistamine drugs on histamine which produced anaphylactic contraction of 
smooth muscle have been explained as a phase of the contraction which is not 
antagonized by the antihistamine (250).
Martin and his colleagues in 1949 reported that flavonoid compounds effectively 
inhibited histidine decarboxylase in tissue cultures. This result probably led them 
to suggest that the antianaphylactic effect of the flavonoid compounds used is the 
result of the ability of these compounds to prevent formation of histamine from 
histidine by inhibiting the enzyme decarboxylase (369).
H istaminopexy
Histamine fixation by experimental methods is a comparatively undeveloped 
field. Theoretically at least, it should be possible to inject some substance locally, 
intravenously or intraperitoneally, which would prevent release or inactivate 
liberated histamine by binding it in some way to molecules in the plasma, tissues, 
and/or a substance included in the injection.
The idea of histaminopexy loses some of its aspects of impossibility when viewed 
as a reversal of histamine release processes, in which loosely bound, inactive hista­
mine (382, 383, 595) is activated. Whether this principle would be applicable to 
endogenous histamine, since exogenous histamine is not supposed to be included 
by the cells, is not known. Nevertheless, Laborde, Parrott, and Urquia in 1953 
showed that normal human serum fixed about one third of the exogenous histamine 
(histamine dihydrochloride 10~fi and 5.0% dialysed human serum) in a solution, 
but that in the majority of the cases the sera from allergic patients showed no re­
duction in activity of the histamine by the sera as was shown by the guinea pig 
ileum test (430). Parrot and Laborde (430) found that the histaminopexic activity 
of sera was controlled to a significant extent by adrenal cortical and adenohypo- 
physeal hormones and was reactivated by cortisone.
The statement that antihistaminic. drugs operate by blocking the response of
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receptors to the stimulating effect of free histamine (468) suggests that the bene­
ficial results of these drugs are not due to their histaminopexic activity.
Blaschko (60) holds that liberated histamine exerts its biological action after 
passing from the circulating and tissue fluids by again being bound to "specifically 
histamine-sensitive patches" on the effector cells' surfaces. If this is proved to be 
the mode by which endogenous histamine operates in allergical reactions, then 
any practical means of desensitizing these histamine-sensitive cell surface patches, 
or to cause them to repel the invading histamine, would certainly be well worth 
considering for use in prophylactic or therapeutic treatment.
A rather novel idea of a contributing factor in histamine control is set forth by 
Parrot and Laborde (430) who describe a histaminopexic, gamma globulin-like 
substance which, subsequent to removal by dialysis of an antihistaminopexic, 
albumin-linked serum fraction (Fraction V of E. J. Cohn), reduced the histamine 
activity of normal human serum about 33 per cent and was at least equally effec­
tive on normal sera of the cat, dog, guinea pig (av. of 10, 39.2%), mouse, and rat 
(av. of 8, 38.7%). However, this histamine-fixing substance failed to bind any of 
the histamine in the sera from most of 51 allergic patients suffering from asthma, 
angioneurotic edema, chronic arthritis, eczema, duodenal or exudative and gastric 
ulcers, hay fever, migraine, rheumatic fever, or tuberculosis exudativa (430). 
Parrot showed in 1955 that adrenalectomy deprived rats of this histaminopexic 
substance, but that it was restored by administration of cortisone (505), and that 
deficiency of ascorbic acid also deprived serum of its histaminopexic action (430).
Reuse (468) holds that the beneficial effects of antihistamine in anaphylaxis are 
the result of these drugs inhibiting "the effects of liberated histamine on effectors", 
as is indicated by muscle tissue in vitro. Ungar (595) cautions that there is a pos­
sibility that proteose activation and histamine release are parallel phenomena 
which are due to a common cause, even though it is known that inhibition of pro­
teolysis suppresses release of histamine (595).
C orticosteroids
At least 29 corticosteroids have been identified in extracts of the adrenal cortex, 
but only about 6 of these have been shown to be active (606). Elkinton and Danow- 
ski (160) show that in general adrenocortical steroids in excess disturb the body 
fluid balance by causing sodium retention and potassium deficits accompanied by 
other significant changes in the salt-water balance, sugar, ionic, and other body 
fluid disturbances. However, very little or no consideration is given to histamine.
ACTH, cortisone, and epinephrine (all antiphlogistic hormones of Selye (520)) 
are antagonistic to histamine. These substances decrease capillary permeability 
and also decrease formation of inflammatory exudate. However, DOC (compound 
S, desoxycorticosterone, desoxycortone) and DOCA (DCA, desoxycorticosterone
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acetate; prophlogistic hormones of Selye), like histamine, cause capillary dilation, 
increased permeability, and increased exudate and thus either have no effect on, 
or actually favor, histaminic action. Cortisone, either administered to, or produced 
within, the animal following administration of ACTH is thought to be converted 
into hydrocortisone within the body before it becomes physiologically active (454).
A C T H  (Adrenocortico tropic
It is generally conceded that ACTH, which is an anterior hypophyseal hormone, 
and cortisone have nearly identical effects since ACTH acts by stimulating the 
adrenal cortex to produce corticosteroids, especially cortisone (221). While Conn 
and co-workers, 1951, have indirectly indicated that ACTH-administration pro- 
produces 17-hydroxycorticosterone (Compound F) as the mediator of its action 
(502). Menkin (388) shows that numerous investigators have found that ACTH 
is as effective in suppressing increased capillary permeability in inflammation in 
adrenalectomized rats as in normal ones. He (388) is convinced that ACTH, by 
suppressing the action of exudin, acts directly in decreasing permeability of the 
capillaries. Menkin (388) further supports the idea of these two hormones having 
different effects by stating that ACTH has no effect on leukotaxin-induced dia- 
pedesis but represses the effects of exudin in producing increased capillary per­
meability, while cortisone has no effect on exudin but inhibits the diapedesis. 
ACTH in excess has been found to induce freckling and pigmentation similar to 
that occurring in Addison's disease, but excessive dosage of cortisone does not 
produce this effect (160). Other less clearcut differences in the effects of ACTH 
and cortisone have been reported.
C ortisone
The chief basis for the early recognition of cortisone as a "wonder drug" for 
treatment of various conditions involving capillary hyperenergy may be attributed 
to its ability to decrease capillary permeability. There are several possible means 
by which cortisone may decrease capillary permeability in normal as well as in 
histamine-induced and other edematous conditions. Romani (489) calls attention 
to the fact that there are numerous contradictions in the literature on the effects 
of cortisone on mast cells. Actually the recorded effects range all the way from pro­
ducing a marked increase in number (489) to the destruction of mast cells (19, 
22, 93).
E pin eph r in e  as P otentiator
There is the possibility that immediately beneficial effects of cortisone in re­
ducing conditions resulting from excessive amounts of histamine, "H-substance", 
leukotaxin, and/or similar agents which increase capillary permeability may be
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due to cortisone increasing release of epinephrine, which constricts arterioles (547), 
and thus decreases capillary dilation and permeability by reducing the volume of 
blood passing through the arterioles and precapillaries. Selye (520) suggests that 
competition for the same aminooxidase system may account for the potentiated 
pressor action of epinephrine derivatives in controlling hyperemia and permea­
bility. However, multiple factors in unknown sequence are probably involved. 
One of these little-appreciated factors may be 5-hydroxytryptamine ("serotonin", 
Spategift of Freund, (520)) which is stored in mast cells (43, 334, 493), in blood 
platelets (557), and probably in other cells. Although it is claimed that human 
blood contains about 0.1 7 /m l of this vasoconstrictor principle (389, 557), at pres­
ent it appears that very little is known about the specific relations of this substance 
to either inflammatory hyperemia or to the effects of either epinephrine or corti­
sone on capillary permeability. However, evidence obtained from more than one 
source "makes it very likely that 5-hydroxytryptamine is the edema-producing 
agent released by substances which damage mast cells" (493).
E ffects of C ortisone
Certain investigators have reported that cortisone inhibits leukotaxin (387) 
and hyaluronidases by forming a complex heparin-lipoprotein which acts as a 
nonspecific antihyaluronidase. Also, with this exception, the mechanism of the 
antiphlogistic action of cortisone appears chiefly to involve the sulfhydryl groups 
(489). Moderately prolonged treatment with cortisone causes various metabolic 
changes, but it is debatable whether it affects polymerization of hyaluronic acid. 
Hyaluronic acid is known to increase the resistance of ground substance to the 
spread of inflammation, and by this means it plays a very important part in con­
trolling edematous effects of increased capillary permeability (20, 148). Thus, it 
appears that enzymic systems may play important roles in histamine-epinephrine 
control of motivation of arterioles and their capillaries.
Cortisone not only has a suppressing action on capillary permeability, but it 
also suppresses formation of new capillaries, as in wound healing (17, 275, 330), 
and in the process of vascularization of tumor, skin, and other grafts (17, 330). 
Cortisone may have a direct antimitotic effect in skin grafting, as well as the com­
monly recognized indirect effect, by inhibiting the process of vascularization of the 
graft (330). Apparently, it is safe to assume that the mode of action of cortisone 
in suppressing capillary growth and in suppressing capillary permeability is 
through its antagonism of histamine, and this process may be abetted by other 
substances reported to be active in increasing capillary permeability in normal and 
inflammatory conditions.
Cortisone, probably as the hydrochloride (454), is a potent anti-inflammatory 
agent, which is supposed to have multiple means of producing this effect. In fact,
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cortisone appears to have at least 3 means of effecting suppression of histaminic 
activity. One of these is its ability to block one or more enzyme systems, but the 
particular enzyme system blocked is unknown (454). A number of investigators 
hold that histamine is produced by decarboxylation of histidine by histidine 
decarboxylase (157, 505, 616). Halpern (238) holds that cortisone inhibits biogene­
sis of histamine, the vulnerable link for which would be histidine decarboxylase. 
The enzyme histaminase destroys histamine by catalyzing its oxidation (335), 
and cortisone is held to be able to supress the inhibitor of this process. Thus, corti­
sone is believed to suppress histamine by interfering with its production and by 
aiding in its destruction. Halpern (237) adds another angle of approach by suggest­
ing that cortisone acts by interfering with the metabolism of tissue histamine, 
more specifically by preventing the degradation of the "combined" form to the 
"free" form of histamine.
Ungar (594) holds that a number of anti-inflammatory drugs which include 
cortisone, act by inhibiting the fibrinolytic system in vivo as well as in vitro. Thus, 
he concludes that all anti-phlogistic hormones accelerate the fibrinolysin-antifi- 
brinolysin reaction. Zweifach, 1953, holds that vasodilation with its attendant 
phenomena can be produced by numerous biological substances, many of which 
are formed by the cells. He sees no need for any proteolytic type of enzymatic 
reaction (594). From this it may be inferred that there are multiple points other 
than those in the fibrinolytic system which can be blocked by cortisone, or other 
anti-inflammatory substances, to prevent release of histamine and/or increased 
permeability of the terminal vascular bed.
D esoxycorticosterones
The variable terminology and abbreviations of the terms used by different 
writers make it difficult to determine just which preparation of desoxycorticos­
terone was used and, in some instances, the conditions under which the prepara­
tion was employed. It appears that under comparable conditions the various 
preparations of the desoxycorticosterones all properly belong in Selye's (529) 
1949 group of prophlogistic hormones; that is, they aid or stimulate histaminic 
vasodilation and increased capillary permeability. The names of some of these 
preparations with their synonyms, as nearly as can be determined, in parentheses 
follow: Desoxycorticosterone (compound S (?), deoxycortone, DO, DOC) and 
desoxycorticosterone acetate (DCA, DOCA, a proprietary brand; deoxycortone 
acetate; percortin, a proprietary brand).
Desoxycorticosterone acetate (DCA) is the form of desoxycorticosterone most 
often employed in experimental and clinical work. In general, DCA exerts a more 
pronounced effect on certain species than on others. Although all rats are suscepti­
ble to the hyalinizing effects of DCA, some strains are more susceptible than others;
CAPILLARY PERMEABILITY 35
while the fowl and rat apparently represent the species most sensitive to its hyali- 
nosis-producing effects (520). This species-susceptibility may be largely responsi­
ble for the seemingly contradictory results reported by certain investigators.
DCA promotes inflammation and wound healing, apparently as a result of its 
phlogistic reaction, and thus it stimulates proliferation of fibroblasts and encour­
ages deposition of collagen (520). Apparently, the beneficial effects of DCA on 
wound healing and its aggravating effects on inflammatory processes are essentially 
similar to the effects of mast cell products. That is, both increase capillary per­
meability in order to afford an adequate supply of blood-borne substances neces­
sary for the formation of fibroblasts and collagen and utilization in forming cica­
tricial tissue and in promoting sustaining tissues, such as connective tissue adnexa, 
neural and vascular structures, in wound healing. This point becomes more ob­
vious when it is recalled that cortisone and ACTH inhibit inflammation and wound 
healing by suppressing the processes which DCA and mast cell products promote
Desoxycorticosterone diethyl acetate appears to be an exception to the general 
rule, for this substance is reported as being slow-acting but, unlike DOCA, it 
"decreases the amount of inflammatory exudate" in croton oil granuloma pouches 
in rats. However, it was found to be only about 20 to 30 per cent as potent as hy­
drocortisone (478).
Percortin, a proprietary preparation of desoxycorticosterone acetate which was 
available in the early 1940's, has been reported to be anti-inflammatory in action 
but, since explanations of this property have not been well supported, it was sug­
gested that the antiphlogistic effects of batches of this substance may not have 
been pure material (388). This conclusion was further supported by the fact that 
the substance in crystalline form obtained from another source had "no anti­
inflammatory effect" (388). However, conditions of the experiment may have 
been such that the expected phlogistic results were not obtained. The work of 
Skelton (538) in which he used antihistamines in a futile effort to antagonize the 
effects of DOCA on castrated, unilaterally nephrectomized, salt-treated rats ap­
parently supports the results obtained by use of percortin.
He also reports that under the conditions of this experiment, it was found that 
antihistamines, phenergen, benzodionole, and trimeton, afforded no significant 
protection to those rats against either the angiotoxic or nephrotrophic effects of 
DOCA as seen in the heart, kidney, and arterioles in the pancreas.
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